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BRIEF REPORT

Immunostimulatory membrane proteins potentiate H. pylori-induced
carcinogenesis by enabling CagA translocation
Matthew G. Vargaa, Cecily R. Woodb, Julia Buttc, Mackenzie E. Ryand, Wei-Cheng Youe, Kaifeng Pane,
Tim Waterboerc, Meira Eppleinf, and Carrie L. Shaffer b,d,g
a

Department of Epidemiology, Lineberger Comprehensive Cancer Center and Gillings School of Global Public Health, University of North
Carolina, Chapel Hill, NC, USA; bDepartment of Veterinary Science, University of Kentucky, Lexington, KY, USA; cInfections and Cancer
Epidemiology, German Cancer Research Center, Heidelberg, Germany; dDepartment of Microbiology, Immunology, and Molecular Genetics,
University of Kentucky, Lexington, KY, USA; eDepartment of Cancer Epidemiology, Peking University Cancer Hospital and Institute, Beijing,
China; fDepartment of Population Health Sciences and Duke Cancer Institute, Cancer Control and Population Sciences Program, Duke
University, Durham, NC, USA; gDepartment of Pharmaceutical Sciences, University of Kentucky, Lexington, KY, USA
ABSTRACT

ARTICLE HISTORY

Infection with Helicobacter pylori is the single greatest risk factor for developing gastric adenocar
cinoma. In prospective, population-based studies, seropositivity to the uncharacterized H. pylori
proteins Hp0305 and Hp1564 was significantly associated with cancer risk in East Asia. However, the
mechanism underlying this observation has not been elucidated. Here, we show that Hp0305 and
Hp1564 act in concert with previously ascribed H. pylori virulence mechanisms to orchestrate
cellular alterations that promote gastric carcinogenesis. In samples from 546 patients exhibiting
premalignant gastric lesions, seropositivity to Hp0305 and Hp1564 was significantly associated with
increased gastric atrophy across all stomach conditions. In vitro, depletion of Hp0305 and Hp1564
significantly reduced levels of gastric cell-associated bacteria and markedly impaired the ability of
H. pylori to stimulate pro-inflammatory cytokine production. Remarkably, our studies revealed that
Hp1564 is required for translocation of the oncoprotein CagA into gastric epithelial cells. Our data
provide experimental insight into the molecular mechanisms governing novel H. pylori pathogeni
city factors that are strongly associated with gastric disease and highlight the potential of Hp0305
and Hp1564 as robust molecular tools that can improve identification of individuals that are highly
susceptible to gastric cancer. We demonstrate that Hp0305 and Hp1564 augment H. pylorimediated inflammation and gastric cancer risk by promoting key bacteria-gastric cell interactions
that facilitate delivery of oncogenic microbial cargo to target cells. Thus, therapeutically targeting
microbial interactions driven by Hp0305/Hp1564 may enable focused H. pylori eradication strate
gies to prevent development of gastric malignancies in high-risk populations.
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Introduction

Infection with the gastric pathogen Helicobacter pylori
is the single greatest risk factor for the development of
gastric adenocarcinoma and is attributable for over
80% of the gastric cancer burden.1 Gastric adenocar
cinoma is the third leading cause of cancer-related
death worldwide, with over half of all incident gastric
cancers occurring within East Asia.2 While the global
prevalence of H. pylori exceeds 50%, less than 3% of
infected individuals will develop adenocarcinoma.1
Therefore, due to the high incidence of this bacterium
in global populations and the relatively low risk of
carcinogenesis, mass eradication strategies are neither
advisable nor feasible. Targeted eradication strategies
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in highly susceptible populations have been shown to
reduce gastric cancer risk.3,4 Thus, identifying specific
predictive factors could enable the development of
powerful screening modalities to pinpoint high-risk
populations that would benefit from targeted eradica
tion and screening strategies.
The H. pylori cag pathogenicity island (cag PAI) is
a strain-specific virulence factor that augments cancer
risk.5,6 The cag PAI encodes a type IV secretion system
(cag T4SS) that facilitates the delivery of peptidogly
can, nucleic acids, lipid metabolites, and the oncopro
tein CagA into host cells.7–9 The majority of people inf
ected by H. pylori harboring the cag T4SS do not
develop cancer,1,10,11 suggesting that other bacterial co
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nstituents affect disease risk. Previously, we employed
a serologic H. pylori biomarker panel to demonstrate
that seropositivity to two uncharacterized H. pylori
proteins encoded by Hp0305 and Hp1564 were asso
ciated with a fourfold increase in the odds of gastric
cancer incidence in a consortium of eight prospective
cohorts from East Asian populations.12 These findings
were then validated as markers of gastric precancerous
lesions in an independent study population from
a high-risk region of Linqu County, China.13 Antibo
dy response to the dual-positivity of Hp0305 and Hp
1564 (referred to as OMP in previous studies) was
superior at predicting incident gastric cancer risk as
well as prevalent precancerous gastric lesions com
pared to detecting H. pylori alone or the secreted
oncoprotein CagA.12,13 Despite the observed associa
tions of Hp0305 and Hp1564 with cancer risk, the
mechanism by which these proteins influence carci
nogenesis remains unknown. Thus, we sought to elu
cidate the role of these proteins in H. pylori-mediated
carcinogenesis in an effort to delineate promising bac
terial factors that could be therapeutically targeted in
novel precise intervention strategies.

Materials and methods
Linqu County study population

Serum samples analyzed for antibody responses to
Hp0305 and Hp1564 as well as levels of pepsinogen
I and II were obtained from the Linqu County inter
vention trial as described previously.13,14 Briefly, in
2002, an intervention trial was established in Linqu
County, Shandong Province, China, to compare the
effect of H. pylori treatment and selective COX-2
inhibitors on precancerous gastric lesions. In total
2,813 residents aged 35–64 were recruited from 12
randomly selected villages in Linqu County. At
baseline entry into the study, participants complet
ed a standard structured questionnaire and provid
ed a blood sample. Participants were also screened
by upper endoscopy15 for presence of superficial
gastritis (SG), chronic atrophic gastritis (CAG), int
estinal metaplasia (IM), indefinite dysplasia (Ind
DYS), dysplasia (DYS), and cancer, following the
criteria of the Updated Sydney System15 and the
Padova International Classification.16 A written in
formed consent was obtained from each participant
and the study was approved by the Institutional

Review Board of Peking University Cancer Hospi
tal (2016KT90).
For the initial study of validating H. pylori anti
body biomarkers associated with precancerous gas
tric lesions, a total of 1,402 individuals screened by
upper endoscopy at baseline were included.13 Of
those individuals, valid pepsinogen I and II levels
were available for a subset of participants, thus, the
present study included only those 546 individuals
(226 controls and 320 cases).
Measurement of serum antibody responses to
Hp0305 and Hp1564

Antibody responses to H. pylori hypothetical pro
teins Hp0305 and Hp1564 were measured as part of
a larger multiplex serology panel including in total
13 H. pylori proteins as described previously.13,17
Briefly, H. pylori proteins were recombinantly
expressed as Glutathione-S-transferase (GST)-tag
fusion proteins in Escherichia coli BL21 and affi
nity-purified on glutathione-coated fluorescently
labeled polystyrene beads (Luminex Corp.). A mix
ture of the differently labeled and antigen-loaded
beads was then incubated with serum to allow
binding of serum antibodies to the H. pylori pro
teins. Bound serum antibodies were detected by
a biotin-labeled anti-human IgM/IgA/IgG second
ary antibody and Streptavidin-R-phycoerythrin.
A Luminex 200 analyzer (Luminex Corp.) then
distinguished between the bead type and consequ
ently the bound antigen as well as quantified the
amount of bound serum antibody as median fluor
escence intensity (MFI) of 100 beads per type mea
sured. Antigen-specific cutoffs were determined as
described in Epplein et al., 2018.13
Detection of pepsinogen I and II in serum

Pepsinogen I and II levels in serum were deter
mined by pepsinogen I and II enzyme-linked
immunosorbent assay (ELISA) (Eagle Biosciences)
according to manufacturer’s instructions and as
described previously.13 The pepsinogen I and II
concentration (ng/ml) in each sample was deter
mined by provided assay standards to obtain a plate
specific standard curve. A ratio of pepsinogen
I over II was calculated for each sample for further
analysis.
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Statistical analyses

Generation of H. pylori isogenic mutant derivatives

As only a few individuals presented with normal
gastric mucosa, study participants with superficial
gastritis (SG) were chosen as the referent group.
Thus, the distribution of demographic characteris
tics among individuals with precancerous lesions
(CAG, IM, Ind Dys, and Dys) was compared to
individuals with SG by Chi-squared test for catego
rical variables and Student’s t-test for continuous
variables. The H. pylori seromarker of combined
Hp0305 and Hp1564 status was applied as defined
in Epplein et al., 201813 as being either dual sero
negative for both proteins, seropositive for either
Hp0305 or Hp1564, or dual seropositive for both
Hp0305 and Hp1564. The pepsinogen I/II ratio as
a continuous variable was compared between the th
ree Hp0305/Hp1564 sero-statuses by Wilcoxon ra
nk-sum test, either in the overall study population
or separately within each stomach condition group
(SG, CAG, IM, Ind Dys, or Dys). A two-sided pvalue<0.05 was considered statistically significant.
For in vitro assays, IL-8 production induced by
H. pylori mutants was compared to corresponding
IL-8 secretion levels induced by the WT strain by
one-way ANOVA with Dunnett’s post-hoc correc
tion for multiple comparisons. For experiments
evaluating levels of adherent and internalized bac
teria, enumerated colony forming units (CFUs) for
each mutant were compared to the WT strain by
two-tailed Mann-Whitney test. For qPCR studies,
transcript levels produced by the cagX mutant were
compared to the corresponding transcript levels
produced by WT by unpaired two-tailed t-test.

H. pylori mutants were generated as previously
described.18 Briefly, H. pylori was transformed with
a suicide plasmid in which the coding region of the
target gene was replaced by either a kanamycin
resistance cassette (Hp0305) or a chloramphenicol
resistance cassette (Hp1564) and homologous flank
ing DNA sequences 500 base pairs (bp) up- and
downstream of the target locus. Colonies resistant
to kanamycin (12.5 μg/ml) or chloramphenicol
(10 μg/ml) were PCR-verified to confirm insertion
of the resistance cassette into the appropriate locus
in the same orientation as operon transcription.
Generation of the Hp0305/Hp1564 double mutant
was constructed by transformation of the Hp1564::
cat derivative with the Hp0305::kan plasmid.
Transformants were selected based on dual resis
tance to kanamycin and chloramphenicol, and
gene deletion was verified by PCR targeting the
insertion locus with comparison to the WT strain.
To complement mutants in cis at the ureA hetero
logous chromosomal locus, we used plasmids derived
from pAD1.18 Plasmids were constructed to permit
expression of C-terminal hemagglutinin (HA) epi
tope-tagged Hp0305 (pAD1-CamR) and Hp1564
(pAD1-KanR). Plasmid sequences were confirmed by
sequencing, and constructs were used to transform
Hp0305 and Hp1564 mutants, respectively. Insertion
of complementation constructs into the ureA locus
was confirmed by PCR amplification, and expression
of the Hp0305-HA and Hp1564-HA epitope-tagged
proteins was verified by immunoblotting using mono
clonal anti-HA antibodies.

Bacterial strains and culture conditions

Generation of TEM-CagA reporter strains

Helicobacter pylori 26695 (ATCC) and its isogenic
derivatives were maintained on trypticase soy agar
plates supplemented with 5% sheep blood (BD
Biosciences) as previously described.18 Overnight
cultures were grown in Brucella broth supplemen
ted with 5% FBS at 37°C with 5% CO2. E. coli DH5α
was grown on Luria-Bertani (LB) agar plates or in
LB liquid medium with appropriate antibiotics
overnight as needed for general cloning and plas
mid propagation.

TEM-CagA expression strains were generated essen
tially as previously described.19 Briefly, a synthetic
gene construct was generated comprising 500 bp up
stream of the endogenous cagA promoter, the E. coli
blaM gene (encoding the TEM-1 β-lactamase) lack
ing the N-terminal signal sequence under the con
trol of the native cagA promoter, and 500 bp do
wnstream of the cagA start codon. The synthetic TE
M-CagA construct was transformed into the cagA::
cat-rdxA strain,18 and counterselection on metroni
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dazole (15 μg/ml) was performed to select positive
clones expressing TEM-CagA. Insertion of the
TEM-CagA construct into the cagA locus was ver
ified by PCR and immunoblot analysis probing for
TEM-CagA production (approximately 160 kDa vs
140 kDa for WT CagA). A TEM-CagA cagE mutant
was generated as previously described18 via trans
formation with a suicide vector in which the cagE
coding region was replaced with a kanamycin resis
tance cassette transcribed in the same direction as
the operon. TEM-CagA cagE mutants were selected
by resistance to kanamycin, and deletion of cagE
was verified by PCR. To generate the TEM-CagA
Hp1564 mutant, the verified TEM-CagA strain was
transformed with the Hp1564::cat construct and was
selected on chloramphenicol as described for muta
genesis of the WT strain. Disruption of the Hp1564
locus was verified by PCR. The corresponding
Hp1564-HA complemented strain was generated
by transformation of the TEM-CagA Hp1564
mutant strain with the pAD-Hp1564-HA construct
and selection on kanamycin. Integration of the
Hp1564-HA expression construct was verified by
PCR and immunoblot analysis probing for
C-terminal HAepitope-tagged Hp1564.
Human cell culture

AGS human gastric epithelial cells (ATCC CRL1739) were cultured in RPMI 1640 medium supple
mented with 10% fetal bovine serum (FBS), 2 mM
L-glutamine, and 10 mM HEPES in the presence of
5% CO2 at 37°C. Primary adult human gastric
epithelial cells (Cell Biologics H-6039) were propa
gated in human epith
elial cell medium supplemented with ITS, EGF,
hydrocortisone, L-glutamine, and 5% FBS (Cell
Biologics H662). HEK293-hTLR9 and the corre
sponding parental HEK293 tlr9-/- reporter cell
lines (InvivoGen) were grown in the presence of 5%
CO2 in DMEM supplemented with 10% heat-inac
tivated FBS and 2 mM L-glutamine.
IL-8 quantitation

Secretion of IL-8 by AGS cells co-cultured with
H. pylori or its isogenic derivatives was determined
using the human CXCL8 ELISA (R&D Systems).
Briefly, AGS cells were infected with H. pylori or

each isogenic mutant for 4.5 h at a multiplicity of
infection (MOI) of 100. Cell-free supernatants were
collected and analyzed as previously described.18
Biological replicate experiments were performed
a minimum of at least three times.
Immunoblot analysis of cag T4SS proteins

H. pylori and its derivatives were propagated on
TSAII plates supplemented with 5% sheep blood
(BD Biosciences) for 24 or 48 h, or in Brucella broth
supplemented with 5% FBS for 16 hours. Bacterial
cultures were normalized to an OD600 of 1.0 prior to
lysis in 2X SDS buffer (Bio-Rad). Standardized sam
ples were resolved by SDS-PAGE, transferred to
nitrocellulose membranes (Bio-Rad), and analyzed
by immunoblotting using either α-CagA or α-CagY
polyclonal antisera.
CagA translocation assays

CagA translocation into AGS cells was performed as
described previously.18 Briefly, AGS cells were
infected at an MOI of 100 in triplicate in for 6 h
prior to at least three washes in 1X PBS to remove
non-adherent bacteria. AGS cells were lysed in buffer
containing 1% NP-40 with cOmplete™ mini EDTAfree protease inhibitor (Roche) and PhosSTOP phos
phatase inhibitor (Roche). The soluble fraction was
separated on a 7.5% gel (Bio-Rad) for immunoblot
analysis probed by an anti-phosphotryosine antibody
(α-PY99, Santa Cruz). Membranes were subsequently
probed for total CagA (α-CagA, Santa Cruz), βtubulin (Invitrogen), and H. pylori outer membrane
protein (α-OMP, Santa Cruz). CagA translocation
assays were performed at least four times per strain,
and the ratio of translocated CagA (pY-CagA) to
total CagA was determined by densitometry analysis
for each strain in biological replicate experiments
using ImageJ as previously described.18
TEM-CagA translocation assays

TEM-CagA translocation was assayed as previously
described.19 Briefly, AGS cells were infected by WT
TEM-CagA or isogenic mutant strains for 2.5 h.
After infection, cells were loaded with the fluores
cent substrate CCF4-AM in loading solution
(LiveBLAzer-FRET B/G loading kit, Invitrogen)
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supplemented with 1 mM probenecid (Sigma). For
fluorescence quantification by plate reader assay,
infected cells were incubated with loading solution
at in the dark for 2.5 h, and fluorescence was mea
sured with a Synergy H1 hybrid multi-mode plate
reader (BioTek) using an excitation wavelength of
410 nm. Emission was detected at 450 nm (blue
fluorescence) and 520 nm (green fluorescence).
Levels of CagA translocation were defined as the
ratio of emission at 450 nm(sample-blank) divided by
the emission at 520 nm(sample-blank), where the blank
wells contained only CCF4-AM loading solution in
cell culture media in the absence of AGS cells and
bacteria. Relative CagA translocation is expressed
as the ratio of 410em/520em, and data are expressed
as the fold change over uninfected controls.
TLR9 activation assays

HEK293 cells expressing a human TLR9 reporter
construct (hTLR9) or parental Null1 cells
(Invivogen) were infected in quadruplicate over
night at an MOI of 100 with H. pylori 26695 or
isogenic mutant strains as previously described.8
TLR9 activation was quantified by measuring secr
eted embryonic alkaline phosphatase (SEAP) repor
ter activity in cell culture supernatants by Quanti
Blue reagent (Invivogen). TLR9 activation was nor
malized to SEAP levels produced by infected tlr9-/parental cells, and is expressed as the fold-change
over mock-infected controls. A minimum of three
biological replicate experiments were performed
for each strain.
Bacterial adherence and internalization assays

H. pylori or its isogenic derivatives were co-cultured
with AGS gastric epithelial cells or HEK293-hTLR9
cells as described for IL-8 induction assays.18 After
4 h of infection, cell culture media was aspirated and
wells were washed three times with PBS to remove
non-adherent bacteria. A subset of wells used to eval
uate total adherent and intracellular bacteria were
replenished with fresh cell culture media. Intracellu
lar levels of H. pylori were assessed by treating the
remainder of the wells with cell culture media sup
plemented with gentamycin (100 μg/mL) and incu
bation for 1 h at 37°C with 5% CO2. Media was
removed, and wells were washed three times in
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sterile PBS to remove residual media and gentami
cin. Infected wells were mechanically lysed in PBS,
and samples were serially diluted on blood agar for
colony enumeration. A minimum of three biological
replicate experiments were performed in triplicate
for each bacterial strain.
RNA isolation and real-time quantitative PCR (qPCR)

To assess transcript levels of target genes in response to
host cell contact, adult primary gastric epithelial cells
were either uninfected or co-cultured with H. pylori
26695 or isogenic derivatives for 4 to 6 h. Cells were
washed with sterile PBS three times before total RNA
isolation by the Direct-Zol Miniprep Plus kit (Zymo
Research) following the manufacturer’s protocol. Total
RNA was digested with Turbo DNase I (Invitrogen)
prior to cDNA synthesis using the iScript cDNA synth
esis kit (Bio-Rad) from 500 ng of total DNA-free RNA
template. cDNA was diluted 1:20, and qPCR was per
formed using TaqMan MGB chemistry as previously
described.18 To assess levels of target gene mRNA in
planktonic culture, H. pylori 26695 and corresponding
derivative strains were grown overnight in Brucella
broth supplemented with 5% FBS, and RNA was pre
pared as described for co-culture samples. cDNA was
generated from 500 ng of total bacterial DNA-free RNA
template. As a control, equivalent concentrations of
DNA-free RNA from each sample were analyzed by
qPCR in parallel. The relative abundance of Hp0305
and Hp1564 transcripts produced when bacteria were
co-cultured with primary gastric cells was calculated
using the ΔΔCT method, with each transcript normal
ized to the abundance of the multiplexed gyrB endo
genous control, and compared to normalized transcript
levels produced by H. pylori in the absence of host cell
contact.
Results
H. pylori Hp0305/Hp1564 seropositivity and
decreased pepsinogen I/II ratios are associated with
precancerous gastric lesions

Among individuals with precancerous gastric lesions,
only those with Ind Dys were more likely to be men
and current smokers as compared to the reference
group of individuals with SG (Table 1). However, for
all precancerous lesion types the seroprevalence of
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H. pylori proteins Hp0305/Hp1564 dual-positivity was
higher (CAG: 33%, IM: 65%, Ind Dys: 54%, Dys: 55%)
than among individuals with SG (17%) (Table 1).
A low pepsinogen I/II ratio is an established serum
marker for presence of CAG in the stomach and
associated with stomach cancer risk. Therefore, we
assessed whether pepsinogen I/II ratios were also asso
ciated with Hp0305/Hp1564 seropositivity in our
study population, and determined whether these para
meters varied with type of premalignant stomach con
dition, i.e. SG, CAG, IM, Ind Dys, and Dys (Figure 1).
Indeed, the pepsinogen I/II ratio was significantly
lower in Hp0305/Hp1564 dual seropositive indivi
duals compared to dual-negative individuals in the
overall study population as well as in all precancerous
lesions (CAG, IM, Ind Dys, and Dys). Thus, Hp0305/
Hp1564 dual-positivity was more common among
individuals with precancerous lesions compared to
SG, and was concordantly associated with a lower
pepsinogen I/II ratio, indicating a greater severity of
gastritis among individuals with a demonstrated
immune response to both H. pylori antigens.

Hp0305 and Hp1564 influence IL-8 cytokine
secretion by gastric epithelial cells

H. pylori-induced carcinogenesis primarily results from
prolonged inflammation of the gastric mucosa. One
marker of H. pylori-induced inflammation is elevated
levels of IL-8.20 Therefore, we assessed the ability of strain
26695 (used to generate the multiplex serology panel
employed in this study) and corresponding mutant
strains lacking either Hp0305, Hp1564, or both

Hp0305/Hp1564 to induce cag T4SS-dependent IL-8
secretion in cultured, immortalized gastric cells.
Compared to uninfected controls or cells infected with
a cagX mutant strain defective in cag T4SS activity,21 we
observed a significant reduction in IL-8 secretion when
gastric epithelial cells were co-cultured with either
Hp0305 (p < .001) or Hp1564 (p < .0001), an effect that
was further compounded by co-culture with the double
knockout Hp0305/Hp1564 (p < .0001) (Figure 2(a)).
Complementation of the Hp0305 and Hp1564 mutants
with Hp0305-HA or Hp1564-HA constructs, respec
tively, restored IL-8 secretion to levels indistinguishable
from WT (Figure 2(a)), confirming a direct role of these
proteins in cag T4SS function. To recapitulate the gastric
niche, we also co-cultured H. pylori strains with adult
primary gastric epithelial cells (Figure 2(b)). As expected,
a cagX-deficient mutant induced significantly less IL-8
secretion compared to the parental strain; however, only
the Hp0305/Hp1564 double mutant exhibited significant
defects in eliciting IL-8 responses compared to either
single mutant strain (Figure 2(b)). Together, these results
suggest that Hp0305 and Hp1564 are associated with cag
T4SS-dependent IL-8 synthesis and secretion in vitro,
which may contribute to the increased oncogenicity
observed in our population-based studies.

Hp1564 is required for translocation of the
oncoprotein CagA into epithelial cells

As all known cag T4SS phenotypes require direct host
cell contact, we next performed gentamicin protection
assays to assess both bacterial adherence and interna
lization into host gastric cells. Compared to the WT

Table 1. Demographic characteristics of the study population, Linqu County, Shandong Province, China, 2002–2004.
Referent group
SG (n = 60)
Sex, n (%)
Female
Male
Age, mean (SD)
Current smoker, n (%)
No
Yes
HP0305/HP1564, n (%)
Dual-negative
Either/or
Dual-positive

CAG (n = 166)

pvalue*

IM (n = 142)

Gastric precancerous lesions
pInd Dys (n = 116)
value*

pvalue*

Dys
(n = 62)

pvalue*

32 (53)
28 (47)
49 (8)

98 (59)
68 (41)
49 (6)

0.444
0.582

79 (56)
63 (44)
50 (6)

0.764
0.519

43 (37)
73 (63)
50 (7)

0.039
0.602

28 (45)
34 (55)
50 (7)

0.367
0.444

35 (58)
25 (42)

113 (68)
53 (32)

0.174

92 (65)
50 (35)

0.386

47 (41)
69 (59)

0.025

31 (50)
31 (50)

0.356

37 (62)
13 (22)
10 (17)

74 (45)
38 (23)
54 (33)

0.038

15 (11)
34 (24)
93 (65)

<0.001

25 (22)
28 (24)
63 (54)

<0.001

12 (19)
16 (26)
34 (55)

<0.001

SG, superficial gastritis; CAG, chronic atrophic gastritis; IM, Intestinal metaplasia; Ind Dys, Indefinite Dysplasia; Dys, Dysplasia;
*Compared to superficial gastritis, Chi-squared test for categorical variables, Student’s test for continuous variables, p-value<0.05 considered
statistically significant (marked in bold font).
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Figure 1. Hp0305 and Hp1564 seropositivity predict gastric inflammation. Pepsinogen I/II ratio by Hp0305/Hp1564 serostatus in (a) the
overall study population and (b) by stomach condition. The pepsinogen I/II ratio was compared between Hp0305- and Hp1564negative individuals (n = 165), and Hp0305- or Hp1564-positive (n = 130) as well as Hp0305 and Hp1564 dual-positive individuals
(n = 251) by Wilcoxon rank-sum test (**, p < .01; ***, p < .001; ****, p < .0001). In (a), -, seronegative; +, seropositive; in (b), SG,
superficial gastritis (n = 60); CAG, chronic atrophic gastritis (n = 166); IM, Intestinal metaplasia (n = 142); Ind Dys, Indefinite Dysplasia
(n = 116); Dys, Dysplasia (n = 62).

strain, Hp1564 displayed significantly reduced levels of
bacterial internalization (p = .04), while the Hp0305/
Hp1564 double mutant displayed significantly
reduced adherence and internalization (p < .001 for
both metrics) when co-cultured with AGS gastric
epithelial cells (Figure 2(c)).
H. pylori strains that harbor the cag T4SS have the
capacity to translocate the bacterial oncoprotein CagA
directly into gastric epithelial cells, and are associated
with a higher gastric cancer risk.11 Therefore, we next
sought to determine whether Hp0305 and/or Hp1564
were required for CagA delivery to gastric cells. Under
standard growth conditions, deletion of Hp0305 and/or
Hp1564 did not significantly alter levels of CagA or the
cag T4SS structural component CagY compared to the
WT or complemented strains (Figure 2(d)). However,
we determined that loss of Hp1564, but not Hp0305,

significantly impaired CagA translocation, an effect that
was also evident in the Hp0305/Hp1564 double mutant
(Figure 2(e)). In addition, H. pylori lacking Hp1564
produced less CagA when co-cultured with gastric
epithelial cells compared to bacteria grown in plank
tonic culture (Figure 2(e)). Analysis of tyrosinephosphorylated CagA (pY-CagA) and total CagA levels
in AGS co-cultures by semi-quantitative densitometry
reveled a significant decrease in the ratio of injected
CagA compared to total CagA in Hp1564-deficient
strains (Figure 2(f)). Complementation with an epi
tope-tagged form of Hp1564 restored the ability to
translocate CagA into host cells to levels comparable
to the WT strain (Figure 2(f)).
To confirm the finding that loss of Hp1564 signifi
cantly reduces CagA translocation independent of qua
litative CagA tyrosine phosphorylation assays, we
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Figure 2. Immunostimulatory H. pylori proteins modulate cag T4SS activity. Levels of IL-8 induced by WT H. pylori and the
corresponding Hp0305, Hp1564, and complemented mutants co-cultured with AGS gastric epithelial cells (a) and adult primary gastric
epithelial cells (b) were quantified by ELISA. Data represent a minimum of three biological replicate experiments for each strain.
(c) H.pylori were co-cultured with AGS gastric cells for 4 hours prior to gentamicin-protection assays and enumeration of the total
adherent and intracellular bacterial colony forming units (CFU). (d) WT H. pylori and the indicated mutants were grown overnight prior
to collection and cell density normalization. The levels of CagA and the cag T4SS structural component CagY were analyzed by
immunoblot. Mutants lacking either Hp0305 or Hp1564 produced CagA and CagY at levels similar to the parental WT strain. (e) AGS
gastric cells were co-cultured with WT H. pylori or the indicated mutant for 6 h. Levels of translocated tyrosine-phosphorylated CagA (αPY99), total CagA (α-CagA), host cell cytoskeleton (α-β-tubulin), and total H. pylori (α-OMP) were assessed by immunoblot. (f) Semiquantitative densitometry analysis was used to determine the levels of tyrosine phosphorylated CagA (pY-CagA) and total CagA for the
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established a quantitative CagA translocation system in
which the E.coli TEM1 β-lactamase is translationally
fused to the N-terminus of CagA (TEM-CagA) and
expressed from the native locus driven by the endogen
ous cagA promoter.19 Translocation of TEM-CagA into
AGS cells is monitored via TEM β-lactamase-mediated
cleavage of the TEM substrate CCF4-AM19 and deter
mination of the ratio of blue (cleaved CCF4-AM) to
green (intact CCF4-AM) fluorescence signal (Figure 2
(g)). In order to determine if Hp1564 inactivation leads
to a reduction in the levels of translocated CagA, we
generated a mutant deficient in Hp1564 and the corre
sponding complemented strain in the H.pylori 26695
[TEM-CagA] background. As anegative control, we
employed an isogenic H.pylori 26695 [TEM-CagA]
cagE mutant in which an ATPase required for cag
T4SS function is inactivated. Under standard infection
conditions, H.pylori 26695 [TEM-CagA] translocated
significantly more TEM-CagA into gastric epithelial
cells compared to the corresponding cagE and
Hp1564 isogenic mutant strains by 2.5 h of infection
(Figure 2(h)). CagA translocation defects exhibited by
the H.pylori 26695 [TEM-CagA] Hp1564 strain were
rescued by complementation with an epitope-tagged
Hp1564 (Figure 2(h)), corroborating our observation
that Hp1564 mutants are associated with significantly
reduced levels of tyrosine-phosphorylated CagA com
pared to the WT strain (Figure 2(e,f)). Taken together,
these results demonstrate that Hp1564 significantly
influences CagA translocation into gastric epithelial
cells.
Hp0305 and Hp1564 are regulated in response to
gastric epithelial cells

In addition to the protein effector CagA, the cag T4SS
has the capacity to deliver chromosomally-derived bac
terial DNA to host cells to activate TLR9.8 In order to
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determine if Hp0305 or Hp1564 also influence cag
T4SS-dependent TLR9 activation, a CagA transloca
tion-independent phenotype, we employed a robust
HEK293-hTLR9 reporter cell line.8 H. pylori deficient
in either Hp0305 or Hp1564 induced high levels of
TLR9 activation that were indistinguishable from the
parental WT strain (Figure 3(a)). Interestingly, althou
gh TLR9 activation was not dependent on either
Hp0305 or Hp1564, H. pylori deficient in both Hp03
05 and Hp1564 were internalized into HEK293hTLR9 cells to a lesser extent than the WT strain, at lev
els similar to the cagX mutant (Figure 3(b)). These da
ta support our previous finding that Hp0305/1564
mutants exhibit an adherence and internalization def
ect when co-cultured with AGS gastric epithelial cells.
Lastly, to determine whether Hp0305 and Hp1564
are regulated in response to host cell contact, we
examined the levels of Hp0305 and Hp1564 mRNA
produced by H. pylori that were co-cultured with pri
mary gastric epithelial cells. Compared to mRNA leve
ls produced by the inoculum, contact with primary
gastric epithelial cells down-regulated the production
of Hp0305 at 6- and 12-h post-infection in the WT
strain (Figure 3(c)), while levels moderately increased
in the cagX mutant strain by 12-h post-infection. In
contrast, co-culture with primary gastric cells stimu
lated the production of Hp1564 at 6- and 12-h postinfection (Figure 3(d)) in both strains. Compared to
transcript levels observed in WT bacteria co-cultured
with primary gastric epithelial cells, the expression of
Hp1564 was significantly increased in the cagX mutant
strain under the same conditions (Figure 3(d)). These
data suggest that during early infection, H. pylori may
up-regulate the expression of Hp1564 as a mechanism
to stimulate cag T4SS activity. Taken together, our
data demonstrate that Hp0305 and Hp1564 are linked
to multiple cag T4SS-dependent phenotypes and drive
key bacterial interactions with gastric cells.

indicated strains in a minimum of four biological replicate experiments. Graph depicts the ratio of translocated CagA to total CagA for
each strain. (g) Schematic of quantitative TEM-CagA translocation assay. Production of the TEM-1 β-lactamase-CagA fusion protein
(TEM-CagA) is driven by the cagA promoter from the endogenous locus. TEM-CagA translocation is monitored by a FRET-based assay in
which CCF4 is loaded into AGS cells 2.5 hours post-infection. TEM-CagA translocation is determined by the ratio of cleaved CCF4
(emission at 450 nm) compared to intact CCF4 substrate (emission at 520 nm). (h) AGS cells were infected with WT or the indicated
mutant strain and were subsequently loaded with CCF4-AM. Turnover of CCF4 by translocated TEM-CagA was monitored by
determining the ratio of substrate emission at 450 nm to the emission at 520 nm. Ratios were normalized to cell-free controls, and
are expressed as the fold change over uninfected AGS cells. Statistical significance was determined by one-way ANOVA with Dunnett’s
post-hoc correction for multiple comparisons in (a), (b), (f) and (h). In (c), enumerated CFUs for each mutant were compared to the WT
strain by two-tailed Mann-Whitney test. (*, p < .05; **, p < .01, ***, p < .001, ****, p < .0001 compared to WT in all panels).
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Figure 3. Hp0305 and Hp1564 are regulated in response to the gastric epithelium. (a) WT H. pylori and the indicated mutant strains
were co-cultured with a HEK293 reporter cell line expressing human TLR9. Normalized levels of TLR9 activation are expressed as the
fold change over the corresponding mock-infected cells. (b) H. pylori were co-cultured HEK293-hTLR9 cells for 4 hours prior to
gentamicin protection assays and enumeration of the total adherent and intracellular bacterial colony forming units (CFU). H. pylori
were co-cultured with human adult primary gastric epithelial cells, and levels of Hp0305 (c) or Hp1564 (d) transcript produced by the
indicated strain was assessed at 6 h and 12 h post-infection. Target transcripts were normalized to the level of gyrB transcript produced
by each strain, and transcript abundance was compared to the level of corresponding normalized transcript produced by H. pylori
cultured in the absence of host cell contact. In (b), enumerated CFUs for each mutant were compared to the WT strain by two-tailed
Mann-Whitney test. In (c) and (d), transcript levels produced by the cagX mutant were compared to WT by unpaired two-tailed t-test (*,
p < .05; **, p < .01, ****, p < .0001 compared to WT in all panels).

Discussion

Our previous prospective studies in East Asia have
demonstrated and further validated that seropreva
lence to the uncharacterized H. pylori proteins
Hp0305 and Hp1564 is significantly associated with
gastric cancer risk.12,13 Here, we demonstrate that
seroprevalence to these proteins is also associated
with increased levels of gastric atrophy (evidenced by
decreased pepsinogen I/II ratios), an established hall
mark of gastric inflammation.
To further define the mechanism underlying the
observation that seropositivity to Hp0305 and Hp1564
is associated with gastric inflammation and gastric
cancer risk, we conducted several in vitro studies
employing H. pylori mutants deficient in Hp0305,
Hp1564, or Hp0305/Hp1564. We demonstrate that
Hp0305 and Hp1564 contribute, at least in part, to
driving a robust inflammatory response in gastric
epithelial cells. To pinpoint the role of these virulence
factors in H. pylori-induced pathologies, we assessed

whether Hp0305 or Hp1564 influence translocation of
the oncoprotein CagA into host cells. Hp1564, but not
Hp0305, is necessary for CagA translocation, while
both genes are required for proper bacterial adhesion
to host cells. Interestingly, TLR9 activation, a phenot
ype dependent on cag T4SS activity, was not affected
by the absence of either Hp0305 or Hp1564. These
results suggest that loss of Hp1564 negatively impacts
CagA translocation independent of additional cag T4
SS-associated phenotypes, including the delivery of
peptidoglycan and nucleic acid substrates to host cells.
Hp0305 is an immunogenic H. pylori membrane
protein that harbors a YceI-like domain with homology
to the lipocalin fold. Previous studies have shown that
Hp0305 is a component of outer membrane vesicles
(OMVs) produced in response to acidic stress condi
tions such as those found in the stomach.22–24 As such,
OMVs play a critical role in bacterial colonization, as
well as delivery and translocation of bacterial virulence
factors. Secreted OMVs are highly immuno genic,
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prompting production of pro-inflammatory cyt
okine and activation of antigen-presenting cells,
as well as induction of innate and adaptive
immune responses.25 These observations regard
ing H. pylori OMVs complement findings from
the current study demonstrating the potential uti
lity of antibody levels to Hp0305 in predicting
gastric cancer risk in a cohort of East Asian
individuals.12 Previous studies designed to char
acterize Hp0305 have found that purified, reco
mbinant Hp0305 binds multiple cell types includ
ing gastric epithelial cells, macrophages, and
neutrophils.23
Furthermore,
recombinant
HP0305 has been shown to induce apoptosis and
TNF expression via ERK/MAPK/SFK signaling
in macrophages.23
Similar to Hp0305, the H. pylori outer membrane
protein Hp1564 has been repeatedly found in culture
supernatants as well as the bacterial cell surface,
suggesting that it is a secreted protein.22,24 In addi
tion, similar to Hp0305, one study identified Hp1564
partitioned within OMVs.26 Other in silico analyses
uncovered Hp1564 homology to membrane-bound
methionine transporters in other bacterial species,
suggesting a role of this previously uncharacterized
protein in amino acid metabolism.27
Although the treatment regimen for H. pylori infec
tion is well established, universal “test and treat” strategies
are not practical given the scale of infection prevalence,
the increased risk of adverse effects of H. pylori eradica
tion in individuals with less-virulent strains, and adher
ence to antibiotic stewardship.4,28–33 As such, there is an
urgent need to identify biomarkers that can specifically
identify those patients at highest risk for gastric cancer
(such as Hp0305 and Hp1564) for targeted eradication
strategies. Our results strengthen previous populationbased studies and delineate the mechanistic basis for their
strong association with gastric cancer risk. Given the high
prevalence of H. pylori colonization among individuals at
risk for development of severe gastric disease, this work
provides the framework for more efficacious treatment
and prevention strategies that specifically target Hp0305/
Hp1564-regulated pathways.
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